Fluorinated benzamide neuroleptics—III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bishop, 1991, Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)- substituted benzamides, J. Med. Chem., 34, 1612, 10.1021/jm00109a013
Boyson, 1986, Quantitative localization of the D-1 and D-2 subtypes of dopamine receptors in rat brain, J. Neurosci., 6, 3177, 10.1523/JNEUROSCI.06-11-03177.1986
Cheng, 1973, Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction, Biochem. Pharmacol., 22, 3099, 10.1016/0006-2952(73)90196-2
Chipkin, 1988, Pharmacological profile of SCH 39166: a dopamine D-1 selective benzonaphthazepine with potential antipsychotic activity, J. Pharm. Exp. Therap., 247, 1093
Chumpradit, 1993, Fluorinated and iodinated dopamine agents: D-2 imaging agents for PET and SPECT, J. Med. Chem., 36, 221, 10.1021/jm00054a005
El Tayer, 1985, Lipophilicity measurements of protonated basic compounds by reversed-phase high performance liquid chromatography, J. Chromatogr., 320, 293, 10.1016/S0021-9673(01)90507-2
Fang, 1992, Alternate syntheses of125I-ioxipride and125I-epidepride: high affinity and selective dopamine D-2 receptor radioligands, J. Nucl. Med., 33, 982
Hall, 1991, Synthesis and binding properties of the fluorinated substituted benzamide3H-NCQ 115, a new selective dopamine D-2 receptor ligand, Eur. J. Pharmacol., 201, 1, 10.1016/0014-2999(91)90315-H
Halldin, 1993, Preparation of two highly potent and selective dopamine D-2 receptor antagonists for PET:18F-NCQ 616 and11C-FLB 457, J. Label. Compds Radiopharm., 32, 282
Hatano, 1991, Syntheses of o- and p-18F-fluorobenzyl bromide and their application to preparation of F-18 labeled neuroleptics, J. Label. Compds Radiopharm., 30, 137
Hogberg, 1989, Efficient stereoconservative syntheses of 1-substituted (S)- and (R)-2- aminomethylpyrrolidines, Acta. Chim. Scand., 43, 660, 10.3891/acta.chem.scand.43-0660
Hogberg, 1990, Potential antipsychotic agents. Part 8. Antidopaminergic properties of a potent series of 5-substituted (−)-(S)-N-[(1-ethylpyrrolidin-2-yl) methyl]-2,3-dimethoxybenzamides. Synthesis via common lithio intermediates, Helv. Chim. Acta., 73, 417, 10.1002/hlca.19900730221
Kessler, 1991, High affinity dopamine D-2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides, J. Nucl. Med., 32, 1593
Kessler, 1992, Evaluation of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5- (3-18F-fluoropropyl)-2,3-dimethoxy-6-hydroxybenzamide (5-FPI), a superior PET ligand for studying cerebral dopamine D-2 receptors, J. Nucl. Med., 33, 847
Kessler, 1993, Evaluation of 5-18F-fluoropropylepidepride as a potential PET radioligand for imaging dopamine D-2 receptors, Synapse, 15, 169, 10.1002/syn.890150302
Kessler, 1993, N-Allyl-5-fluoropropylepidepride—a very potent and specific dopamine D2 PET radioligand, J. Nucl. Med., 34, 202P
Lannoye, 1990, N-Fluoroalkylated and N-alkylated analogues of the dopaminergic D-2 receptor antagonist raclopride, J. Med. Chem., 33, 2430, 10.1021/jm00171a017
Mach, 1993, 18F-Labeled benzamides for studying the dopamine D-2 receptor with positron emission tomography, J. Med. Chem., 36, 3707, 10.1021/jm00075a028
Maeda, 1992, Positron-emitting N-18F-fluoroalkyl and18F-fluoropyrrolidinyl analogues of eticlopride as potential in vivo radioligands for dopamine D-2 receptors, Chem. Pharm. Bull., 40, 1793, 10.1248/cpb.40.1793
Mathis, 1990, High affinity aryl-substituted18F- fluoroalkylbenzamides for PET D-2 studies, J. Nucl. Med., 31, 737
Mathis, 1992, Synthesis and evaluation of high affinity, aryl-substituted18F-fluoropropylbenzamides for dopamine D-2 receptor studies, Nucl. Med. Biol., 19, 571
McPherson, 1985, Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC, J. Pharmacol. Meth., 14, 213, 10.1016/0160-5402(85)90034-8
Munson, 1980, LIGAND: a versatile computerized approach for characterization of ligand binding systems, Anal. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1
Murakami, 1991, Antidopaminergic effects of the stereoisomers of N-[(1-alkyl-2-pyrrolidinyl)methyl]-5-sulfamoylbenzamides and -2,3-dihydrobenzofuran-7-car☐amides, J. Med. Chem., 34, 261, 10.1021/jm00105a041
Mukherjee, 1990, Use of diethylaminosulfur trifluoride in an efficient synthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl)-methyl]-5-(3-fluoropropyl)-2-methoxybenzamide, J. Fluorine Chem., 49, 151, 10.1016/S0022-1139(00)80372-3
Mukherjee, 1991, Fluorinated benzamide neuroleptics 2. Synthesis and radiosynthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(3-18F-fluoropropyl)-3-substituted-2-methoxybenzamide, Int. J. Appl. Radiat. Isotopes, 42, 713, 10.1016/0883-2889(91)90174-Y
Mukherjee, 1990, Dopamine D-2 receptors imaged by PET in Cebus apella using18F-benzamide neuroleptic, Eur. J. Pharmacol., 175, 363, 10.1016/0014-2999(90)90578-T
Mukherjee, 1992, Synthesis, pharmacological and lipophilicity studies of improved analogs of the D-2 receptor PET tracer, [F-18]FPMB, Ann. Univ. Turkuensis., 88, 59
Mukherjee, 1993, [F-18]Fallypride as an improved PET radiotracer for dopamine D-2 receptors, J. Nucl. Med., 34, 243P
de Paulis, 1985, Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides, J. Med. Chem., 28, 1263, 10.1021/jm00147a025
de Paulis, 1991, 97
Rognan, 1990, Optically active benzamides as predictive tools for mapping the dopaminergic D-2 receptor, Eur. J. Pharmacol., 189, 59, 10.1016/0922-4106(90)90230-U
Schmidt, 1994, Aromatic and amine substituent effects on the apparent lipophilicities of N-[(2-pyrrolidinyl)methyl]- substituted benzamides, J. Pharm. Sci., 83, 305, 10.1002/jps.2600830309
Seeman, 1989, Endogenous dopamine lowers the dopamine D-2 receptor density as measured by3H-raclopride, Synapse, 3, 96, 10.1002/syn.890030113
Seeman, 1990, Evaluation of dopamine D-2 receptors in schizophrenia is underestimated by radioactive raclopride, Arch. Gen. Psych., 47, 1170, 10.1001/archpsyc.1990.01810240090014
Votaw, 1993, Quantification of striatal and extrastriatal dopamine D-2 receptors using N-allyl-[F-18]FPE, J. Nucl. Med., 34, 132P